Eversept Partners, LP Ocular Therapeutix, Inc Transaction History

Eversept Partners, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$9.7 - $14.34 $1.46 Million - $2.15 Million	-150,000 Closed	0 $0
Q2 2021 Nov 08, 2023	BUY	$13.43 - $19.16 $2.01 Million - $2.87 Million	150,000 New	150,000 $2.13 Million
Q2 2021 Aug 16, 2021	BUY	$13.43 - $19.16 $2.01 Million - $2.87 Million	150,000 New	150,000 $2.13 Million

172

138M

150K

225K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $705M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.